Anzil Meditech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.00 M
- Revenue Growth 216.84%
- Profit Growth 480.49%
- Ebitda 443.01%
- Net Worth 446.80%
- Total Assets 299.97%
About Anzil Meditech
Anzil Meditech Private Limited (AMPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 20 February 2018 (Six years and 11 months 19 days old ). Its registered office is in Ghaziabad, Uttar Pradesh, India.
The Company is engaged in the Engineering Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.00 M.
Rubi, Veerwala, and Rajesh Kumar serve as directors at the Company.
Company Details
-
Location
Ghaziabad, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U93090UP2018PTC101146
-
Company No.
101146
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 Feb 2018
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Anzil Meditech?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rubi
|
Director | 20-Feb-2018 | Current |
|
Veerwala
|
Director | 20-Feb-2018 | Current |
|
Rajesh Kumar
|
Director | 20-Feb-2018 | Current |
Financial Performance of Anzil Meditech.
Anzil Meditech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 216.84% increase. The company also saw a substantial improvement in profitability, with a 480.49% increase in profit. The company's net worth Soared by an impressive increase of 446.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Anzil Meditech?
In 2022, Anzil Meditech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Bhargas India Private LimitedRajesh Kumar is a mutual person
Charges (Loans)
₹1.00 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Oct 2023 | Hdfc Bank Limited | ₹1.00 M | Open |
How Many Employees Work at Anzil Meditech?
Unlock and access historical data on people associated with Anzil Meditech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Anzil Meditech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anzil Meditech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.